Only first intravitreal bevacizumab injection achieves statistically significant visual improvement in naïve myopic choroidal neovascularization
Paolo Milani, Amedeo Massacesi, Stefano Ciaccia, Marco Setaccioli, Stefania Moschini, Fulvio BergaminiDipartimento di Oculistica, Istituto Auxologico Italiano, Milano, ItalyBackground: The aim of this study was to evaluate the efficacy of intravitreal bevacizumab when administered on an as-needed ba...
Enregistré dans:
Auteurs principaux: | Bergamini F, Moschini S, Setaccioli M, Ciaccia S, Massacesi A, Milani P |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Dove Medical Press
2012
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/8853ba05e850495e89b7caf57fc51a6f |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Multimodal imaging and diagnosis of myopic choroidal neovascularization in Caucasians
par: Milani P, et autres
Publié: (2016) -
Intravitreal aflibercept versus bevacizumab for treatment of myopic choroidal neovascularization
par: Jia-Kang Wang, et autres
Publié: (2018) -
Single intravitreal ranibizumab for myopic choroidal neovascularization
par: Shatriah I, et autres
Publié: (2011) -
Treatment of myopic choroidal neovascularization with intravitreal ranibizumab injections: the role of age
par: Karagiannis D, et autres
Publié: (2017) -
Choroideremia associated with choroidal neovascularization treated with intravitreal bevacizumab
par: Palejwala NV, et autres
Publié: (2014)